FDA Warns Sanofi-Aventis (France) About Plant Violations, Cited For Not Reporting Problems With Multaq and Other Drugs

February 23, 2011 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Boston Globe -- Sanofi-Aventis SA has received warning letters from the Food and Drug Administration regarding its facilities in Germany and New Jersey.

Twitter
LinkedIn
Facebook
Email
Print

Food and Drug Administration (FDA) Sanofi (France)